Jing Zhou

Dr. Jing Zhou


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2018 in Molecules
Verified
Journal Article
Open access
PDF file
JZJing Zhou
Jing Zhou
LZLincheng Zhang
Lincheng Zhang
QLQinping Li
Qinping Li
WJWeifeng Jin
Weifeng Jin
WCWeiyan Chen
Weiyan Chen
YZYuyan Zhang
Yuyan Zhang
The ultrasonic-assisted extraction process and antioxidant activity of flavonoids from Sophora flavescens were investigated in this study. In order to optimize the extraction of flavonoids from Sophora flavescens, the influence of extraction time, methanol concentration, ultrasonic temperature, and solvent-to-material ratio was analyzed. Results showed that the extraction yields reached a maximum with the extraction time of 30 min, methanol concentration of 80%, temperature of 80 °C, and solvent-to-material ratio of 26 mL/g. The flavonoids were determined by HPLC, and the mean yields of trifolirhizin, formononetin, isoxanthohumol, maackiain, and kurarinone under the optimal conditions were 2.570, 0.213, 0.534, 0.797, and 3.091 mg/g, respectively. The evaluation of vitro antioxidant activity exhibited Sophora flavescens flavonoids had a strong 1,1-diphenyl-2-picrylhydrazyl (DPPH) and hydroxyl radical-scavenging ability with IC50 of 0.984 and 1.084 mg/g, respectively. These results indicate that ultrasonic-assisted extraction is an efficient approach for the selective extraction of flavonoids, and response surface methodology further optimized the extraction.

16 June 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SCSimiao Chen
Simiao Chen
JZJinghui Zhang
Jinghui Zhang
MLMin Li
Min Li
JZJing Zhou
Jing Zhou
YZYuyan Zhang
Yuyan Zhang
Current therapy for ischemic stroke primarily relies on tissue plasminogen activator (tPA), but it is limited by narrow treatment time window, bleeding complications and neurotoxicity. The preliminary study of tPA plus Danhong injection (DHI) shows that it can significantly reduce the side effects of tPA and improve its thrombolytic effect, but the mechanism of this action has not been further studied. In this study, the rats were randomly divided into sham group, vehicle group, DHI group (4 mL/kg), tPA group (5 mg/kg) and DHI+tPA group (4 mL/kg+ 2.5 mg/kg), administered intravenously 4.5 h since focal embolic stroke modeling. After 3 days and 7 days of cerebral ischemia, the neurological function of each treatment group was significantly improved compared with the vehicle group. The combination of DHI and tPA significantly reduced Evans blue (EB) penetration as well as the expressions of the proteins MMP-9, PAI-1 and P-selectin, while upregulating the expressions of claudin-5, occludin, and ZO-1 mRNA. Furthermore, the effect of continuous 7-day treatment was more conspicuous than 3-day treatment. Then, it significantly reduced the expressions of the proteins DLL-4 and VEGFR-2, increased the expressions of Notch-1, HIF-1α and HES-1 mRNA, and promoted the expressions of VEGF/HIF-1α-positive cells at 14 days following stroke. Hematoxylin-eosin (HE) staining and transmission electron microscopy (TEM) also showed that it improved pathological changes of ischemic brain tissue and the cerebral cortex micro-structure. These indicate that DHI combined with tPA may significantly ameliorate blood-brain barrier (BBB) disruption by activating Notch-VEGF signaling pathway to promote angiogenesis for long-term outcomes.

15 March 2025 in Phytomedicine
Verified
Journal Article
Closed access
BMBiying Ma
Biying Ma
WWWenqi Wang
Wenqi Wang
ZLZhongxia Li
Zhongxia Li
CZChao Zhong
Chao Zhong
JZJing Zhou
Jing Zhou
YWYiqi Wang
Yiqi Wang

20 June 2026 in Molecular Brain
Verified
Journal Article
Open access
SDShuhui Deng
Shuhui Deng
ZZZhuchen Zhou
Zhuchen Zhou
ZCZhong Chen
Zhong Chen
YZYanrong Zheng
Yanrong Zheng
JZJing Zhou
Jing Zhou
OptoH 3 R is an artificial fusion protein that combines the photosensitive elements of rhodopsin with the signaling domain of the histamine H 3 receptor (H 3 R), enabling light-controlled activation of downstream H 3 R pathways. Although our previous study demonstrated that OptoH 3 R mimics the acute effects of H 3 R activation on neuronal activity, whether this tool can also recapitulate the long-term receptor desensitization and internalization processes associated with prolonged H 3 R activation remains unclear. In this study, primary cortical neurons and HeLa cells were employed to investigate the alterations in subcellular localization of OptoH 3 R upon sustained photoactivation, with histamine-stimulated wild-type (WT) H 3 R serving as a control. Furthermore, the role of β-arrestin in this process was explored. Time-lapse fluorescence imaging revealed that the number of puncta progressively increased over time following laser stimulation. Subsequent co-staining experiments with endosome marker EEA1 showed that 75.5% of light‑induced puncta were EEA1‑positive. Notably, the increase in OptoH 3 R-positive vesicles within neuronal cells was attenuated by the β-arrestin inhibitor barbadin, a pattern consistent with the internalization observed in histamine-stimulated WT H 3 R. Collectively, our findings demonstrate that OptoH 3 R recruits β-arrestin signaling upon sustained optical stimulation, thereby recapitulating H 3 R desensitization dynamics. This establishes OptoH 3 R as a useful tool for dissecting the spatiotemporally specific functions of H 3 R, including both its acute signaling and long-term β-arrestin-related mechanisms.